<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Tolebrutinib Slows Disability Progression in MS, but Elevated Liver Enzymes Need to be Monitored

Default sub title

1 minute read

by Neurology Today | April 8, 2025
placeholder

Topics: Press Coverage